Impact of Delay Prior to Treatment in Ethiopian Children with Acute Lymphoblastic Leukemia

References

• World Health Organization. WHO Global Initiative for Childhood Cancer – An Overview. Vol. 5. World Health Organization; 2020.
   Google Scholar
• Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18(6):719–731.
   PubMed Web of Science ®Google Scholar
• Force LM, Abdollahpour I, Advani SM, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. Lancet Oncol. 2019;20(9):1211–1225.
   PubMed Web of Science ®Google Scholar
• Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood, and adolescent cancer statistics. CA Cancer J Clin. 2014;64(2):83–103.
   PubMed Web of Science ®Google Scholar
• Gupta S, Howard SC, Hunger SP, et al. Treating childhood cancer in low- and middle-income countries; 2008:121–146.
   Google Scholar
• Gatta G, Rossi S, Foschi R, et al. Survival and cure trends for European children, adolescents, and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002. Haematologica. 2013;98(5):744–752.
   PubMed Web of Science ®Google Scholar
• Tandon S. Acute leukemia treatment in low - and middle - income countries: is it time for tailored therapy? Cancer Res Stat Treat. 2020;3:18–19.
   Google Scholar
• Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105(11):2524–2539.
   PubMed Web of Science ®Google Scholar
• Friedrich P, Lam CG, Itriago E, et al. Magnitude of treatment abandonment in childhood cancer. PLoS One. 2015;10(9):1–15.
   Web of Science ®Google Scholar
• Lins MM, Amorim M, Vilela P, et al. Delayed diagnosis of leukemia and association with morbid-mortality in children in Pernambuco, Brazil. J Pediatr Hematol Oncol. 2012;34(7):271–276. doi:10.1097/MPH.0b013e3182580bea
   PubMed Web of Science ®Google Scholar
• De Angelis C, Pacheco C, Lucchini G, et al. The experience in Nicaragua: childhood leukemia in low income countries—the main cause of late diagnosis may be “medical delay”. Int J Pediatr. 2012;2012:5 pages. doi:10.1155/2012/129707
   Google Scholar
• Agrawal V, Kayal S, Ganesan P, Dubashi B. Chemotherapy delays are associated with inferior outcome in acute lymphoblastic leukemia: a retrospective study from a tertiary cancer center in South India. Indian J Med Paediatr Oncol. 2021;42(1):51–60.
   Google Scholar
• Rubnitz JE, Lensing S, Zhou Y, et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude Experie Cancer. 2004;101:1677–1684.
   Google Scholar
• Hargrave DR, Hann IM, Richards SM, et al. Progressive reduction in treatment related deaths in Medical Research Council childhood lymphoblastic leukemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol. 2001;112:293299.
   Web of Science ®Google Scholar
• Prucker C, Attarbaschi A, Peters C, et al. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster Study Group. Leukemia. 2009;23:1264–1269.
   PubMed Web of Science ®Google Scholar
• Gupta S, Bonilla M, Valverde P, et al. Treatment-related mortality in children with acute lymphoblastic leukemia leukemia in Central America: incidence, timing and predictors. Eur J Cancer. 2012;48(9):1363–1369.
   PubMed Web of Science ®Google Scholar
• Singh SK, Lupo PJ, Scheurer ME, et al. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine. 2016;95(46):pe5300. doi:10.1097/MD.0000000000005300
   Web of Science ®Google Scholar
• Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996;14(1):18–24. PMID: 8558195. doi:10.1200/JCO.1996.14.1.18
   PubMed Web of Science ®Google Scholar
• Begum M, Islam M, Akhtar M, Karim S. Evaluation of delays in diagnosis and treatment of childhood malignancies in Bangladesh. South Asian J Cancer. 2016;5:192–193.
   PubMedGoogle Scholar
• Fajardo-Gutiérrez A, Sandoval-Mex AM, Mejía-Aranguré JM, Rendón-Macías ME, Martínez-García Mdel C. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol. 2002;39(1):2531.
   Google Scholar
• Chukwu BF, Ezenwosu OU, Ikefuna AN, Emodi IJ. Diagnostic delay in pediatric cancer in Enugu, Nigeria: a prospective study. Pediatr Hematol Oncol. 2015;32(2):164–171.
   PubMed Web of Science ®Google Scholar
• Brown BJ, Ajayi SO, Ogun OA, Oladokun R. Factors influencing time to diagnosis of childhood cancer in Ibadan, Nigeria. Afr Health Sci. 2009;9(4):247–253.
   PubMed Web of Science ®Google Scholar
• Njuguna F, Martijn H, Langat S, et al. Factors influencing time to diagnosis and treatment among pediatric oncology patients in Kenya. Pediatr Hematol Oncol. 2016;:33(3):186–199.
   PubMed Web of Science ®Google Scholar
• Carpenter K, Slone AK, Scheuer M, Mehta PS, Slone JS. Factors influencing diagnostic delays of pediatric cancers in Botswana. Pediatr Blood Cancer. 2020;2022:e28182.
   Google Scholar
• Yadalla W, Al-Jadiry MF, Faraj SA, et al. Delay in diagnosis of cancer in Iraq: implications for survival and health outcomes at Children’s Welfare Teaching Hospital in Baghdad. J Glob Health. 2021;5:e2021047.
   Google Scholar
• Suzy A, Shaimaa K, Ahmed M, Ashraf F. Delays in diagnosis and treatment among children with cancer: Egyptian perspective. EMHJ. 2017;23:6.
   Google Scholar
• Baker JM, To T, Beyene J, Zagorski B, Greenberg ML, Sung L. Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: a population-based study. Leuk Res. 2014;38(2):204–209.
   PubMed Web of Science ®Google Scholar
• Pui CH, Yang JJ, Hunger SP, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015;33(27):2938–2948.
   PubMed Web of Science ®Google Scholar
• Mostert S, Sitaresmi MN, Gundy CM, Veerman AJ. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics. 2006;118(6):e1600–e1606.
   PubMed Web of Science ®Google Scholar
• Cooper SL, Brown PA. Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):61–73.
   PubMed Web of Science ®Google Scholar
• Seif A, Fisher B, Li Y, et al. Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61(5):846–852. doi:10.1002/pbc.24855
   PubMed Web of Science ®Google Scholar
• O’Connor D, Bate J, Wade R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056–1061).
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Kato M, Imamura T, et al. InHospital management might reduce induction deaths in pediatric patients with acute lymphoblastic leukemia: results from a Japanese cohort. J Pediatr Hematol Oncol. 2021;43(2):39–46. doi:10.1097/MPH.000000000000192
   PubMed Web of Science ®Google Scholar
• Khan M, Naseem L, Manzoor R, Yasmeen N. Mortality analysis in children during induction therapy for acute lymphoblastic leukemia. Int J Cancer. 2013;132:427–436.
   PubMedGoogle Scholar
• Maaz A, Mahmood T. High infection-related mortality in Pakistani children with acute lymphoblastic leukaemia during remission induction chemotherapy: review of data from a single institution. JCancer Allied Spec. 2016;2(4):6.
   Google Scholar
• Wolf J, Flynn P, Gaur A, et al. Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia. Clin Infect Dis. 2017;65(11):1790–1798.
   PubMed Web of Science ®Google Scholar
• Fadoo Z, Nisar I, Yousuf F, et al. Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle-income population: a multi-institutional report from Pakistan. Pediatr Blood Cancer. 2015;62:1700–1708.
   PubMed Web of Science ®Google Scholar
• Abdul Mabood S, Fouda AE, Boujettif F, Mansour A. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival. J Pediatr. 2020;96:108--–16.
   Google Scholar
• Wahl SK, Gildengorin G, Feusner J. Weekend delay in initiation of chemotherapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2011;34(1):e8–e11.
   Web of Science ®Google Scholar
• Suarez A, Pina M, Nichols-Vinueza D, et al. A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays. Pediatr Blood Cancer. 2015;62:1395–1402.
   PubMed Web of Science ®Google Scholar
• Loh AH, Aung L, Ha C, Tan AM, Quah TC, Chui CH. Diagnostic delay in pediatric solid tumors: a population-based study on determinants and impact on outcomes. Pediatr Blood Cancer. 2012;58(4):561–565.
   PubMed Web of Science ®Google Scholar
• Kulkarni KP, Marwaha RK, Trehan A, Bansal D. Survival outcome in childhood ALL: experience from a tertiary care center in North India. Pediatr Blood Cancer. 2009;53:168–173.
   PubMedGoogle Scholar
• Amelia Y, Anna C, Kahlia F, et al. Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia, Pediatric. Hematol Oncol. 2017;34:38–42.
   Google Scholar